feed,title,long_url,short_url
Barron's,Revance Stock Is Plunging. The FDA Wonâ€™t Clear a Treatment for Frown Lines.,https://www.barrons.com/articles/revance-stock-is-plunging-the-fda-wont-clear-a-treatment-for-frown-lines-51634566191?mod=RTA,https://j.mp/2YZXJO2
